These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 12153334

  • 1. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
    Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F.
    CNS Drugs; 2002; 16(9):635-43. PubMed ID: 12153334
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [Abstract] [Full Text] [Related]

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 4. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.
    J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
    [Abstract] [Full Text] [Related]

  • 5. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses.
    Shen J, Kennedy SH, Levitan RD, Kayumov L, Shapiro CM.
    J Psychiatry Neurosci; 2005 Jan; 30(1):11-6. PubMed ID: 15644992
    [Abstract] [Full Text] [Related]

  • 6. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA, Schweizer E, Rickels K.
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [Abstract] [Full Text] [Related]

  • 7. Which depressed patients respond to nefazodone and when?
    Trivedi MH, Rush AJ, Pan JY, Carmody TJ.
    J Clin Psychiatry; 2001 Mar; 62(3):158-63. PubMed ID: 11305700
    [Abstract] [Full Text] [Related]

  • 8. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 9. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Ninan PT, Rush AJ, Crits-Christoph P, Kornstein SG, Manber R, Thase ME, Trivedi MH, Rothbaum BO, Zajecka J, Borian FE, Keller MB.
    J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
    [Abstract] [Full Text] [Related]

  • 10. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G, Frare F, Toni C, Ruffolo G, Torti C.
    Neuropsychobiology; 2002 May; 46(3):145-9. PubMed ID: 12422062
    [Abstract] [Full Text] [Related]

  • 11. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
    Rickels K, Schweizer E, Case WG, DeMartinis N, Greenblatt DJ, Mandos LA, Garcia España FG.
    J Clin Psychopharmacol; 1998 Apr; 18(2):145-53. PubMed ID: 9580369
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U.
    J Clin Psychiatry; 1995 Sep; 56 Suppl 6():37-42. PubMed ID: 7649972
    [Abstract] [Full Text] [Related]

  • 18. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
    Sánchez-Lacay JA, Lewis-Fernández R, Goetz D, Blanco C, Salmán E, Davies S, Liebowitz M.
    Depress Anxiety; 2001 Sep; 13(3):118-24. PubMed ID: 11387731
    [Abstract] [Full Text] [Related]

  • 19. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Sep; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 20. Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Saper JR, Lake AE, Tepper SJ.
    Headache; 2001 May; 41(5):465-74. PubMed ID: 11380644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.